Yi Qin

Yi Qin currently serves as Director of Product Management for New Analytes and New Applications and Director of Strategic Marketing for Hospital at Dexcom since December 2022. Prior to joining Dexcom, Yi Qin held various leadership positions at Fortive from 2019 to December 2022, including General Manager of Core Terminal Sterilization and Global Commercial Fortive Business System Leader. Earlier experience includes serving as Product Director at Johnson & Johnson from 2015 to 2019, where responsibilities encompassed US commercial marketing for Advance Sterilization Products and participation in the Marketing Leadership Development Program. Yi Qin began a career in marketing and product management at Johnson & Johnson and has also held a leadership role at Santa Cruz Biotechnology. Yi Qin earned an MBA in Marketing and International Business from USC Marshall School of Business and a BA in Biochemistry and Molecular Biology from the University of California, Berkeley.